The Role of p53 in Brain Tumors
Author Information
Author(s): Burns A S Y W, Jaros E, Cole M, Perry R, Pearson A J, Lunec J
Primary Institution: Cancer Research Unit, Medical School University of Newcastle
Hypothesis
Is the expression of p53 protein in primitive neuroectodermal tumors associated with patient survival?
Conclusion
High levels of p53 protein in central primitive neuroectodermal tumors are linked to poorer patient survival.
Supporting Evidence
- 101 patients with cPNETs were studied for p53 expression.
- High p53 staining intensity was significantly associated with poor survival.
- DNA mutations in the p53 gene were infrequent in the tumors analyzed.
Takeaway
This study found that when a protein called p53 is very high in certain brain tumors, it usually means the patient might not live as long.
Methodology
Immunohistochemistry was used to analyze p53 protein expression, and DNA sequencing was performed on selected samples.
Potential Biases
Potential bias in patient selection and retrospective data collection.
Limitations
The study only analyzed pre-treatment samples and may not reflect changes after treatment.
Participant Demographics
Patients with central primitive neuroectodermal tumors, including 80 medulloblastomas, aged primarily between 3 and 12 years.
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.0001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website